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We read with interest the article by Darke and Duflou [1] published in Addiction.  Darke and 
Duflou examined the proportions of cases in which 6-monoacetyl morphine (6-AM) was present 
in the blood, and compared concentrations of secondary metabolites and circumstances of death 
by 6-AM status. They found 6-AM was detected in 43% of cases. The median free morphine 
concentration of 6-AM positive cases was more than twice that of 6-AM negative cases. 6-AM 
positive cases also had lower concentrations of the other major heroin metabolites: morphine-3-
glucuronide (M3G) and morphine-6-glucuronide (M6G) with correspondingly lower 
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M3G/morphine and M6G/morphine ratios. Darke and Duflou conclude that in heroin-related 
deaths in their study sample, 6-AM was present in the blood in under half of cases, suggesting 
that a minority of cases had survival times after overdose of under 20-30 minutes. They believe 
that the toxicology of heroin metabolites and the circumstances of death were consistent with 6-
AM as a proxy for a more rapid death [1].  
We wonder if any urine 6-AM was tested in those decedents who tested negative for blood 6-AM 
or what percentage of blood 6-AM positive also had positive urine 6-AM?  If death occurred 
shortly after heroin intake, then very small or no 6-AM would be expected in the urine. If death 
occurred in a delayed fashion, one would expect relatively high 6-AM concentration in the urine 
related to the concentrating effect of kidney [2]. The usually described window of time for 6-AM 
detection in urine is between 2 and 8 h after injection of heroin, because the enzymatic 
hydrolysis of heroin is limited due to the lack of esterase [2]. We wonder if the ratio of blood 6-
AM concentration to urine 6-AM concentration may better represent the proxy for a more rapid 
death? Further, urine 6-AM may help define an estimate of survival time as Darke and Duflou 
have acknowledged that in their 6-AM negative cases, they could not accurately predict how 
long survival times were [1].  
Finally, Darke and Duflou emphasize that their toxicological data on morphine and its major 
metabolites supported 6-AM as a measure of survival times, i.e., cases in which 6-AM was 
present had higher free morphine concentrations, and lower concentrations of M3G and M6G, 
than other cases. Interestingly, Carroll and colleagues [3] conducted an investigation, prompted 
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by review of nine medical examiner cases that, on initial analysis 1 to 2 weeks after death, had 
only a trace amount or no free morphine detected in the blood but that, on re-examination 1.5 to 
26 months later, found between 54 and 560 ng/ml free morphine in the reanalyzed blood 
specimens. They hypothesized that the hydrolases might still be active in bacterially 
contaminated autopsy specimens, despite preservation and refrigeration. Carroll et al. further 
have demonstrated that the hydrolysis of M3G to free morphine in vitro occurs and may persist 
for months, in antemortem and postmortem specimens under various conditions, despite using 
gray-top tubes for inhibition of bacterial growth. Therefore, did the bacterial hydrolysis of 
morphine metabolites confound the M3G and M6G/morphine ratios?  
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